Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia
- PMID: 15540243
- DOI: 10.1002/cncr.20742
Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia
Comment on
-
Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia.Cancer. 2004 Jun 15;100(12):2592-7. doi: 10.1002/cncr.20285. Cancer. 2004. PMID: 15197801